208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1818616490504486912 |
|---|---|
| author | Mary Woodall-Jappe A Raghav Chari Anil Namboodiripad Chandrasekhar Goda |
| author_facet | Mary Woodall-Jappe A Raghav Chari Anil Namboodiripad Chandrasekhar Goda |
| author_sort | Mary Woodall-Jappe |
| collection | DOAJ |
| first_indexed | 2024-12-16T16:50:38Z |
| format | Article |
| id | doaj.art-7a133fa480894f00b51d476c3ad34212 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-16T16:50:38Z |
| publishDate | 2020-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-7a133fa480894f00b51d476c3ad342122022-12-21T22:24:02ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0208208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor modelsMary Woodall-Jappe0A Raghav Chari1Anil Namboodiripad2Chandrasekhar Goda3Aff1 grid.418767.bEisai Inc. Andover MA USA 2Dr. Reddy’s Laboratories, Princeton, NJ, USA2Dr. Reddy’s Laboratories, Princeton, NJ, USA2Dr. Reddy’s Laboratories, Princeton, NJ, USA |
| spellingShingle | Mary Woodall-Jappe A Raghav Chari Anil Namboodiripad Chandrasekhar Goda 208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models Journal for ImmunoTherapy of Cancer |
| title | 208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models |
| title_full | 208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models |
| title_fullStr | 208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models |
| title_full_unstemmed | 208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models |
| title_short | 208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models |
| title_sort | 208 e7777 denileukin diftitox enhances anti tumor activity and significantly extends survival benefit of anti pd 1 in syngeneic solid tumor models |
| work_keys_str_mv | AT marywoodalljappe 208e7777denileukindiftitoxenhancesantitumoractivityandsignificantlyextendssurvivalbenefitofantipd1insyngeneicsolidtumormodels AT araghavchari 208e7777denileukindiftitoxenhancesantitumoractivityandsignificantlyextendssurvivalbenefitofantipd1insyngeneicsolidtumormodels AT anilnamboodiripad 208e7777denileukindiftitoxenhancesantitumoractivityandsignificantlyextendssurvivalbenefitofantipd1insyngeneicsolidtumormodels AT chandrasekhargoda 208e7777denileukindiftitoxenhancesantitumoractivityandsignificantlyextendssurvivalbenefitofantipd1insyngeneicsolidtumormodels |